Variant report

Variant	esv1838362
Chromosome Location	chr10:824504-831747
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:12)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:12 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:735583..738437-chr10:825634..828452,2	MCF-7	breast:
2	chr10:733976..736630-chr10:829821..832143,2	MCF-7	breast:
3	chr10:632878..635792-chr10:829676..832349,2	MCF-7	breast:
4	chr10:826973..829121-chr10:832494..834058,2	K562	blood:
5	chr10:634195..634721-chr10:829974..830911,3	MCF-7	breast:
6	chr10:778218..778962-chr10:824579..825446,5	MCF-7	breast:
7	chr10:819060..821540-chr10:825309..827354,2	MCF-7	breast:
8	chr10:826973..829590-chr10:832494..835604,4	K562	blood:
9	chr10:733970..741093-chr10:828125..835309,12	MCF-7	breast:
10	chr10:550299..552878-chr10:830515..832425,2	MCF-7	breast:
11	chr10:778218..778758-chr10:824666..825446,2	MCF-7	breast:
12	chr10:829650..833485-chr10:834016..837949,4	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000151240	chromatin interactions

Extended variants
information (count: 429 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:429 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs79604393	chr10:824505-824506	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs375173582	chr10:824563-824564	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs563273626	chr10:824593-824594	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs139995298	chr10:824598-824599	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs566284267	chr10:824608-824609	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs142752660	chr10:824611-824612	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs559473610	chr10:824616-824617	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs535016347	chr10:824623-824624	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs551415608	chr10:824657-824658	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs11815869	chr10:824693-824694	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs530125364	chr10:824704-824705	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs540290004	chr10:824716-824717	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs537091999	chr10:824731-824732	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs564765544	chr10:824736-824737	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs7082617	chr10:824777-824778	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs374882430	chr10:824783-824784	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs567993613	chr10:824809-824810	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs536912056	chr10:824814-824815	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs7898132	chr10:824815-824816	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs573336516	chr10:824863-824864	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs538764025	chr10:824870-824871	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs61831428	chr10:824880-824881	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs112309171	chr10:824882-824883	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs575645364	chr10:824894-824895	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs371614890	chr10:824911-824912	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs11814728	chr10:824956-824957	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs560914892	chr10:824957-824958	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs569117406	chr10:824982-824983	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs531534671	chr10:824984-824985	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs60992989	chr10:825005-825006	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs528330780	chr10:825024-825025	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs551284295	chr10:825041-825042	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs75588383	chr10:825044-825045	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs568300457	chr10:825091-825092	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs530605778	chr10:825120-825121	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs554694241	chr10:825132-825133	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs550609344	chr10:825173-825174	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs567242970	chr10:825187-825188	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs11253436	chr10:825207-825208	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs547465655	chr10:825221-825222	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs376683469	chr10:825228-825229	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs74494036	chr10:825307-825308	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs567041371	chr10:825340-825341	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs115042076	chr10:825374-825375	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs113845286	chr10:825383-825384	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs570471911	chr10:825384-825385	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs539406428	chr10:825425-825426	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs111867473	chr10:825426-825427	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs575351583	chr10:825459-825460	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs111296746	chr10:825461-825462	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	20409316	CNVD
Gastric adenocarcinoma	19115996	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Breast cancer	17133270	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Cancer	21129771	CNVD
Sudden cardiac death	19188705	CNVD
Digeorge syndrome	22283845	CNVD
Colorectal cancer	20709793	CNVD
Wilms tumour	19047088	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Barakat syndrome	22470819	CNVD
Melanoma	18172304	CNVD
Ovarian cancer	21720365	CNVD
Autism	18414403	CNVD
Malignant melanoma	18718029	CNVD
Breast cancer	22032731	CNVD
Medulloblastoma	16783165	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Melanoma	17363583	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21785460	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	21509527	CNVD
Prostate cancer	18632612	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Glioblastoma multiforme	21525872	CNVD
Breast cancer	21858162	CNVD
Obesity	19966786	CNVD
Aortic dissecting aneurysms	22263138	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:319 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:818400-830600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr10:821800-824600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
3	chr10:822000-825000	Weak transcription	Stomach Smooth Muscle	stomach
4	chr10:822000-825000	Weak transcription	NH-A	brain
5	chr10:822000-825400	Weak transcription	Osteobl	bone
6	chr10:822000-830400	Weak transcription	Esophagus	oesophagus
7	chr10:822800-825400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr10:824000-825200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
9	chr10:824400-825200	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr10:824600-825000	Enhancers	Placenta Amnion	Placenta Amnion
11	chr10:824600-825200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
12	chr10:824600-825200	Enhancers	HUES6 Cell Line	embryonic stem cell
13	chr10:824600-825400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr10:824600-825400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
15	chr10:825000-825200	Bivalent Enhancer	HepG2	liver
16	chr10:825000-825400	Enhancers	ES-I3 Cell Line	embryonic stem cell
17	chr10:825000-825400	Enhancers	Stomach Smooth Muscle	stomach
18	chr10:825000-825400	Enhancers	NH-A	brain
19	chr10:825200-826800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr10:825400-830400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
21	chr10:825400-830400	Weak transcription	NH-A	brain
22	chr10:826800-827000	ZNF genes & repeats	Pancreas	Pancrea
23	chr10:826800-827200	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr10:827000-829200	Weak transcription	Pancreas	Pancrea
25	chr10:827200-827400	Strong transcription	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr10:827400-828800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr10:828400-828600	Bivalent Enhancer	HepG2	liver
28	chr10:828600-828800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
29	chr10:828600-828800	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
30	chr10:828600-829000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
31	chr10:828800-829000	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr10:828800-829000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
33	chr10:828800-829800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr10:828800-831200	Weak transcription	Fetal Heart	heart
35	chr10:829000-829400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
36	chr10:829000-829800	Enhancers	Brain Inferior Temporal Lobe	brain
37	chr10:829200-829400	Enhancers	Pancreas	Pancrea
38	chr10:829200-830400	Enhancers	Ovary	ovary
39	chr10:829400-829600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
40	chr10:829400-829600	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
41	chr10:829400-829600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
42	chr10:829400-829600	Enhancers	Lung	lung
43	chr10:829400-829600	Bivalent Enhancer	HepG2	liver
44	chr10:829400-829800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
45	chr10:829400-829800	Flanking Active TSS	Pancreas	Pancrea
46	chr10:829400-829800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
47	chr10:829600-829800	Enhancers	Brain Angular Gyrus	brain
48	chr10:829600-829800	Enhancers	Brain Cingulate Gyrus	brain
49	chr10:829600-829800	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
50	chr10:829600-829800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links